Additionally, the analysis of 21 colon cancer (CRC) patients showed a decrease in PP2A activity, which was likely caused by the observed overexpression of both SET and CIP2A in CRC as well as the downregulation of the regulatory subunits, PPP2R2A and PPP2R5E [22]. This evidence concerns the gene PTPA and colorectal carcinoma.